Medical researchers need cutting-edge tools to create new treatments, and Vancouver, BC startup ScopeSys wants to provide them.
Founded in 2017 and tracing its roots to research from University of British Columbia biophysicist Sabrina Leslie, ScopeSys uses physics to make testing new medicines quicker and cheaper.
The 7-person company, which recently closed a $1.1 million seed funding round, is developing tools that let drugmakers observe individual RNA and DNA molecules, giving researchers a more precise way to design new forms of medicines.
We caught up with ScopeSys CEO Padma Kodukula — a longtime biotech leader who most recently served as…
Read the full article at GEEKWIRE.COM